Chronic occupational stress is associated with adverse cardiovascular, metabolic, and mental-health outcomes, but the biological evidence linking workplace exposures to immune–inflammatory dysregulation varies in directness and clinical relevance. This narrative review distinguishes findings demonstrated directly in oc...
Ancuța-Ramona Boicea Camen, Mihai-Virgil Boldeanu, D. Caragea et al.· Diagnostics· 0 citations
Rubella infection during pregnancy poses significant risks, including congenital rubella syndrome (CRS), miscarriage, and fetal death. Vaccination programs have reduced rubella incidence globally, but regional differences in coverage and immunity persist. The objective of the study was to assess the seroprevalence...
Luiza Cristiana Radoi-Troaca, O. Cristea, O. Zlatian et al.· Frontiers in Medicine· 0 citations
Multidisciplinary management, comprising intensive medical support, prompt targeted antibiotic therapy, and immediate surgical intervention, was critical for achieving favorable patient outcomes, and increasing antibiotic resistance may alter the prognosis in patients with NF.
C. Obleagă, P. Leru, S. Cazacu et al.· Medicina· 0 citations
Current evidence linking shift work with gastrointestinal dysfunction and disease is synthesized while distinguishing epidemiological associations from experimental mechanistic evidence and biologically plausible but insufficiently validated relationships, to determine whether occupational, behavioral, or mechanism-bas...
Ancuța-Ramona Boicea Camen, D. Caragea, Mihai-Virgil Boldeanu et al.· Diagnostics· 0 citations
Baseline inflammatory and erythrocyte-derived indices, including the novel composite markers MCVL and IIC, have limited prognostic utility in multiple myeloma, and dynamic changes in inflammatory biomarkers during treatment may provide more clinically relevant information regarding disease progression.
Alexandra-Ștefania Stroe-Ionescu, L. Boldeanu, A. Pǎtraşcu et al.· Biomedicines· 0 citations
CRC was associated with increased circulating oxidative stress biomarkers, with MDA showing the most consistent relationships with systemic inflammatory parameters and survival outcomes, and MDA is identified as a promising candidate oxidative–inflammatory marker warranting external validation rather than an independen...
R. Marinescu, Daniela Marinescu, A. Ciurea et al.· Medicina· 0 citations
Current evidence supports the gut microbiome as a mechanistically plausible contributor, potential biomarker, and therapeutic target in AD while underscoring the need for longitudinal, phenotype-aware, and externally validated studies before routine clinical translation.
L. Boldeanu, A. Ghenea, Marius-Bogdan Novac et al.· Biomedicines· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
